← Leaderboards
Sarah C Glover
University Of Illinois At Chicago
$2,849,916
Attributed
$5,513,441
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $822K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,513,441 · 4
By mechanism
R01$4,541,792 · 2
R21$971,649 · 2
Top collaborators
- Gill Diamond7 shared
- Bruce H Horwitz5 shared
- Matthew J Hamilton2 shared
- Liza Konnikova2 shared
- Larry A. Sklar2 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Afsar Raza Naqvi$3,619,801
- Ana Karina B Bedran-Russo$7,783,918
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectTissuesLinkCellsPlayEpitheliumPathway InteractionsResponseSurfaceLifeBaseCessation Of LifeEpithelial CellsSignal TransductionLeadCharacteristicsCytokineCell MotilityRegulationMolecularInflammatoryFlow CytometryExhibitsPhenotype
Grant awards (15)
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway$741,811
R01 · FY2025 · DE · contact PI
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway$737,561
R01 · FY2024 · DE · contact PI
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway$764,413
R01 · FY2023 · DE · contact PI
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway$1
R01 · FY2023 · DE · contact PI
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway$822,036
R01 · FY2022 · DE · contact PI
Repurposing Pharmacological Agents for Inherited Mast CellDisorders of the Gut$258,460
R21 · FY2020 · TR
Innate immune mechanisms of periodontal disease and inflammatory bowel disease$230,468
R21 · FY2020 · DE · contact PI
Repurposing Pharmacological Agents for Inherited Mast CellDisorders of the Gut$276,817
R21 · FY2019 · TR
Innate immune mechanisms of periodontal disease and inflammatory bowel disease$205,904
R21 · FY2019 · DE · contact PI
Role of Surface Roughness in Regulating Tumor Cell Behavior$271,451
R01 · FY2012 · CA · contact PI
Role of Surface Roughness in Regulating Tumor Cell Behavior$283,076
R01 · FY2011 · CA · contact PI
Role of Surface Roughness in Regulating Tumor Cell Behavior$289,463
R01 · FY2010 · CA · contact PI
Role of Surface Roughness in Regulating Tumor Cell Behavior$289,463
R01 · FY2009 · CA · contact PI
Role of Surface Roughness in Regulating Tumor Cell Behavior$53,054
R01 · FY2009 · CA · contact PI
Role of Surface Roughness in Regulating Tumor Cell Behavior$289,463
R01 · FY2008 · CA · contact PI